代谢综合征与房颤患者缺血性卒中风险:ARIC研究
本研究基于ARIC队列,纳入1172例在测量代谢综合征组分后5年内发生房颤的参与者,中位随访14.8年出现113例缺血性卒中。校正CHA2DS2-VASc变量后,代谢综合征及其组分与缺血性卒中风险均无显著关联,提示代谢综合征不太可能改善房颤患者的卒中预测。
要点
- 校正CHA2DS2-VASc变量后,代谢综合征≥3个组分与缺血性卒中无显著关联(HR 1.38,95%CI 0.91-2.11)。
- 低HDL与卒中风险呈边缘关联(HR 1.48,95%CI 0.99-2.21),其余代谢综合征组分无显著关联。
- 每增加一个代谢综合征组分,卒中风险增加13%,但仅为边缘显著(HR 1.13,95%CI 0.99-1.28)。
核心结论
- 校正CHA2DS2-VASc变量后,代谢综合征与房颤患者缺血性卒中无显著关联,考虑代谢综合征不太可能改善房颤患者的卒中预测。
研究设计与样本
- ARIC研究纳入1172例在测量代谢综合征组分后5年内发生房颤的参与者,代谢综合征分别按ATP标准和国际糖尿病联盟标准定义,缺血性卒中由医师裁定,采用多变量Cox比例风险回归分析。
主要发现
- 中位随访14.8年共发生113例缺血性卒中。
- 校正CHA2DS2-VASc变量后,低HDL与卒中风险呈边缘关联(HR 1.48,95%CI 0.99-2.21),其余代谢综合征组分无显著关联。
- 代谢综合征≥3个组分与缺血性卒中无显著关联(HR 1.38,95%CI 0.91-2.11)。
- 每增加一个代谢综合征组分,卒中风险增加13%,但仅为边缘显著(HR 1.13,95%CI 0.99-1.28)。
临床怎么用
- 在房颤患者卒中风险评估中,代谢综合征及其组分不宜作为独立预测因素额外纳入CHA2DS2-VASc评分体系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Metabolic syndrome (MetS), a prothrombotic state, is associated with an increased risk of atrial fibrillation (AF) and stroke. The CHA2DS2-VASc score does not account for the MetS components of prehypertension, prediabetes mellitus, abdominal obesity, elevated triglycerides, and low HDL (high-density lipoprotein). Data are limited on the association of MetS with stroke in AF, independent of CHA2DS2-VASc variables. Our aim was to identify MetS components associated with ischemic stroke in participants with AF in the ARIC study (Atherosclerosis Risk in Communities). Methods- We included 1172 participants with incident AF within 5 years of measurement of MetS components. MetS was defined by ATP criteria and International Diabetes Federation criteria. Incident ischemic stroke was physician adjudicated. Multivariable Cox proportional hazards regression was used to assess the association of MetS components with stroke. Results- After a median follow-up of 14.8 years, there were 113 ischemic stroke cases. Of the individual MetS components, low HDL was borderline associated with increased stroke risk (hazard ratio, 1.48 [95% CI, 0.99-2.21]) after adjustment for CHA2DS2-VASc variables while the remaining MetS variables were not associated with stroke risk. The presence of ≥3 components of MetS was not significantly associated with ischemic stroke after adjustment for CHA2DS2-VASc variables (hazard ratio, 1.38 [95% CI, 0.91-2.11]). The risk of stroke increased by 13% for each additional component of MetS; however, this association was borderline significant (hazard ratio, 1.13 [95% CI, 0.99-1.28]). Conclusions- The presence of MetS was not significantly associated with ischemic stroke after adjustment for CHA2DS2-VASc variables. Consideration of MetS is unlikely to improve stroke prediction in AF.
引用
- Decker JJ, Norby FL, Rooney MR, et al. Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study. Stroke. 2019. PMID: 31623543. doi:10.1161/STROKEAHA.119.025376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。